PSMA+ mCRPC Expert Roundtables Podcast: Redefining Prostate Cancer in the Era of Advanced Diagnostics expert roundtables By Neeraj Agarwal, MD, FASCO; Peter R. Carroll, MD, MPH; William K. Oh, MD
PSMA+ mCRPC Integrating Recent FDA Approvals for Metastatic Castration-Resistant Prostate Cancer Into Clinical Practice clinical topic updates By Neeraj Agarwal, MD, FASCO
PSMA+ mCRPC Balancing Precision in Patient Selection With Equitable Access to Therapy patient care perspectives By Neeraj Agarwal, MD, FASCO
PSMA+ mCRPC PARP Inhibitor Benefit in Patients With Metastatic Castration-Resistant Prostate Cancer clinical topic updates By Neeraj Agarwal, MD, FASCO
PSMA+ mCRPC The Evolving Role of Prostate-Specific Membrane Antigen Positron Emission Tomography Across the Prostate Cancer Disease Continuum patient care perspectives By Neeraj Agarwal, MD, FASCO